637
We describe the infectious toxicities experienced by the first two patients in our institution treated with dexamethasone (10 mg/m(2)/day for 4 weeks with gradual tapering) during induction according to the dexamethasone arm of BFM 2000 and review the relevant literature that suggests an increased risk of infectious complications with dexamethasone.
 first two patients in our institution: Subject; two: Subject.Age; infectious toxicities: Effect; treated with dexamethasone (10 mg/m(2)/day for 4 weeks with gradual tapering) during induction according to the dexamethasone arm of BFM 2000: Treatment; dexamethasone: Treatment.Drug; dexamethasone: Treatment.Drug; 10 mg/m(2)/day: Treatment.Dosage; m(2)/day: Treatment.Freq; 4 weeks: Treatment.Time_elapsed
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 first two patients in our institution: Subject; two: Subject.Age; infectious toxicities: Effect; treated with dexamethasone (10 mg/m(2)/day for 4 weeks with gradual tapering) during induction according to the dexamethasone arm of BFM 2000: Treatment; dexamethasone: Treatment.Drug; dexamethasone: Treatment.Drug; 10 mg/m(2)/day: Treatment.Dosage; m(2)/day: Treatment.Freq; 4 weeks: Treatment.Time_elapsed